Company Filing History:

7 out of 40

Mercian Corporation

patents

1 out of 677

Eisai Company, Limited

patents

1 out of 527

Eisai R&d Management Co., Ltd.

patents

4. 1 out of 1

Mercian Corporation and Eisai Co., Ltd.

patent

5. 1 out of 947

Chugai Seiyaku Kabushiki Kaisha

patents

where one patent can have more than one assignee

Years Active: 1998-2010

where 'Filed Patents' based on already Granted Patents

9 patents (USPTO):Sort by Forward Citations

Abstract keywords

1. 7667052 - Bioactive substance (2010-02-23),

2. 7026352 - Physiologically active substances (2006-04-11),

3. 6645996 - Physiologically active substances (2003-11-11),

4. 6410759 - Dihydroxycholesterol hydroxylated at 17- and 25-positions (2002-06-25),

5. 6361987 - Gene encoding a protein having asymmetric hydrolase activity for 4-substituted 1,4-dihydropyridine derivatives and its expression product (2002-03-26),

6. 6146844 - Process for producing hydroxylated cholesterols and (2000-11-14),

7. 6143541 - Gene encoding a protein having symmetric hydrolase activity for (2000-11-07),

8. 6043050 - Biological process for producing steroids hydroxylated at the 25-position (2000-03-28),

9. 5760238 - 1,4-dihydropyridine derivatives (1998-06-02),

Title: Innovator Spotlight: Kazuyuki Dobashi Revolutionizing Bioactive Substances

Introduction: Meet Kazuyuki Dobashi, a prolific inventor based in Kanagawa, Japan, with a remarkable track record of 9 patents under his belt. His innovative work in developing bioactive substances is shaping the landscape of medical advancements globally.

Latest Patents: Among his latest patents is the groundbreaking discovery of a bioactive substance with potent antitumor properties. This novel 12-membered ring macrolide compound, derived from the incubation solution of sp. Mer. 11107, showcases immense potential in the field of medicine. Furthermore, his contributions extend to physiologically active substances, where he has pioneered a process for producing and utilizing these compounds for medical purposes.

Career Highlights: Kazuyuki Dobashi has left an indelible mark at esteemed companies such as Mercian Corporation and Eisai Company, Limited. Through his dedication and expertise, he has significantly advanced the development of innovative pharmaceutical products that are revolutionizing healthcare practices.

Collaborations: Along his journey, Dobashi has collaborated closely with notable professionals in the industry, including individuals like Takeo Yoshioka and Takashi Nakashima. These collaborations have been instrumental in bringing his visionary ideas to fruition and driving forward progress in the field of bioactive substances.

Conclusion: In conclusion, Kazuyuki Dobashi stands out as a pioneering inventor with a passion for pushing the boundaries of scientific discovery. His cutting-edge work in developing bioactive substances underscores his commitment to improving human health and underscores the transformative impact of innovation in the medical field. With a bright future ahead, Dobashi continues to inspire others in the pursuit of groundbreaking inventions that have the power to change lives.

This text is generated by artificial intelligence and may not be accurate.

Please report any incorrect information to support@idiyas.com

1 patent (EPO):

Please report any incorrect information to support@idiyas.com

Inventor’s Patent Attorneys refers to legal professionals with specialized expertise in representing inventors throughout the patent process. These attorneys assist inventors in navigating the complexities of patent law, including filing patent applications, conducting patent searches, and protecting intellectual property rights. They play a crucial role in helping inventors secure patents for their innovative creations.